OTCMKTS:SZLSF Stagezero Life Sciences (SZLSF) Stock Price, News & Analysis $0.01 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Stagezero Life Sciences Stock (OTCMKTS:SZLSF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SZLSF alerts:Sign Up Key Stats Today's Range$0.0117▼$0.011750-Day Range$0.01▼$0.0252-Week Range$0.00▼$1.00VolumeN/AAverage Volume15 shsMarket Capitalization$1.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview StageZero Life Sciences Ltd is a molecular diagnostics company focused on the early detection of multiple cancers through non-invasive blood tests. The company leverages proprietary biomarker panels that integrate genomic and proteomic signals to identify cancer at its earliest stages. By offering a single-tube assay, StageZero aims to streamline cancer screening and improve patient outcomes through timely diagnosis and treatment. The company’s flagship product, known as the Polaris multi-cancer early detection test, combines DNA methylation markers with protein analytes to screen for a broad spectrum of solid tumors. Polaris is currently used in clinical studies and select commercial settings across North America, with ongoing efforts to secure broader regulatory clearances. StageZero collaborates with research institutions, hospitals and laboratory partners to validate its technology and expand its testing capabilities into new cancer types and geographies. Headquartered in Canada, StageZero Life Sciences operates laboratories and development facilities in both Canada and the United States, and is exploring strategic partnerships to extend its reach into Europe and Asia. The company is led by a management team with extensive experience in biotechnology, diagnostics and healthcare commercialization. StageZero continues to invest in research and development aimed at enhancing assay performance, scaling laboratory operations and establishing reimbursement pathways for multi-cancer screening solutions.AI Generated. May Contain Errors. Read More Receive SZLSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stagezero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SZLSF Stock News HeadlinesStageZero Life Sciences Ltd. (SZLSF)July 27, 2024 | finance.yahoo.comStageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational UpdateMay 17, 2024 | finanznachrichten.de$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal. | Brownstone Research (Ad)StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade OrderApril 5, 2024 | finanznachrichten.deStagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75MNovember 15, 2023 | seekingalpha.comStageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special MeetingJune 7, 2023 | finance.yahoo.comDually-Listed Healthcare Stock Rallies On Q1 ResultsMay 17, 2023 | theglobeandmail.comStageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023May 15, 2023 | finance.yahoo.comSee More Headlines SZLSF Stock Analysis - Frequently Asked Questions How have SZLSF shares performed this year? Stagezero Life Sciences' stock was trading at $0.0016 on January 1st, 2025. Since then, SZLSF stock has increased by 631.3% and is now trading at $0.0117. How do I buy shares of Stagezero Life Sciences? Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryN/A Current SymbolOTCMKTS:SZLSF CIK1454263 Webwww.stagezerolifesciences.com Phone(855) 420-7140Fax905-209-2031Employees80Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.80 million Price / Sales0.38 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares123,550,000Free Float120,415,000Market Cap$1.45 million OptionableNot Optionable Beta-0.02 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:SZLSF) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stagezero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stagezero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.